These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 19081172)

  • 21. Quality of reporting of diagnostic accuracy studies on pelvic floor three-dimensional transperineal ultrasound: a systematic review.
    Grob ATM; van der Vaart LR; Withagen MIJ; van der Vaart CH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):451-457. PubMed ID: 28000958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
    Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
    Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
    Cardo L; García BP; Alvarez FV
    Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reporting quality of diagnostic accuracy studies: a systematic review and meta-analysis of investigations on adherence to STARD.
    Korevaar DA; van Enst WA; Spijker R; Bossuyt PM; Hooft L
    Evid Based Med; 2014 Apr; 19(2):47-54. PubMed ID: 24368333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SAFE project: towards non-invasive prenatal diagnosis.
    Maddocks DG; Alberry MS; Attilakos G; Madgett TE; Choi K; Soothill PW; Avent ND
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):460-5. PubMed ID: 19290882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First trimester noninvasive fetal RHD genotyping using maternal dried blood spots.
    Xiong Y; Jeronis S; Hoffman B; Liebermann DA; Geifman-Holtzman O
    Prenat Diagn; 2017 Apr; 37(4):311-317. PubMed ID: 28081297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
    Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
    BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.
    Burch J; Hinde S; Palmer S; Beyer F; Minton J; Marson A; Wieshmann U; Woolacott N; Soares M
    Health Technol Assess; 2012; 16(34):1-157, iii-iv. PubMed ID: 22985954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotyping approach for non-invasive foetal RHD detection in an admixed population.
    Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM
    Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A; Tounta G; Mavrou A
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
    Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
    Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
    Prenat Diagn; 2005 Nov; 25(11):1040-4. PubMed ID: 16231312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood.
    Bustamante-Aragonés A; Rodríguez de Alba M; Perlado S; Trujillo-Tiebas MJ; Arranz JP; Díaz-Recasens J; Troyano-Luque J; Ramos C
    Gene; 2012 Aug; 504(1):144-9. PubMed ID: 22561692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive antenatal RHD typing.
    Van der Schoot CE; Soussan AA; Koelewijn J; Bonsel G; Paget-Christiaens LG; de Haas M
    Transfus Clin Biol; 2006; 13(1-2):53-7. PubMed ID: 16564727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.
    Doescher A; Petershofen EK; Wagner FF; Schunter M; Müller TH
    Transfusion; 2013 Feb; 53(2):353-62. PubMed ID: 22691192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Legler TJ
    Prenat Diagn; 2011 Dec; 31(13):1300-4. PubMed ID: 22030893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of high-throughput non-invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross-sectional survey of maternity units and expert interviews.
    Ryczek E; White J; Carolan-Rees G
    Transfus Med; 2020 Aug; 30(4):287-294. PubMed ID: 32447792
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.